Early treatment of thrombotic microangiopathy, a rare and serious complication after heart transplant

Volume: 40, Issue: 11, Pages: 1481 - 1482
Published: Nov 1, 2021
Abstract
Thrombotic microangiopathy (TMA) is a rare disorder characterized by endothelial injury and thrombosis, and the triad of thrombocytopenia, non-immune hemolytic anemia and end-organ failure. 1 Riedl M Fakhouri F Le Quintrec M et al. Spectrum of complement-mediated thrombotic microangiopathies: Pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost. 2014; 40: 444-464https://doi.org/10.1055/s-0034-1376153 Crossref PubMed...
Paper Details
Title
Early treatment of thrombotic microangiopathy, a rare and serious complication after heart transplant
Published Date
Nov 1, 2021
Volume
40
Issue
11
Pages
1481 - 1482
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.